Retinal Damage in Sickle Cell Disease in Abidjan (Ivory Coast)

The objective is to describe the epidemiological, clinical and therapeutic aspects of retinal damage in sickle cell disease. This was a cross-sectional, descriptive analytical study, conducted from November 2022 February 2023, i. e. for period 4 months private ophthalmology centre Abidjan at University Hospital Cocody (Côte d'Ivoire). It focused on patients seen consultation. A total 50 patients, 100 eyes were included, corresponding sample. data entered analysed using SPSS software. mean age 30 years ±10.495. Sickle disease SC most frequent form (52%). Half (50%) had with 34% proliferative retinopathy (34 eyes). common Goldberg angiographic stage III (73.53%). Laser photocoagulation performed eyes. Retinal often patients. Stage neovascularisation barrier that must not be crossed, as consequences are dramatic irreversible blindness. necessary prevent formation or promote regression neovessels. Screening should annual especially fluorescein angiography.